Navigation Links
ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities
Date:11/23/2009

IRVINE, Calif., Nov. 23 /PRNewswire/ -- Advanced Sterilization Products (ASP), a leading global infection prevention solution provider, announced today the acquisition by its French affiliate, Apsis S.A.S., of Gloster Europe, a privately held developer of innovative disinfection processes and technologies to prevent healthcare-acquired infections. Terms of the acquisition were not disclosed.

Gloster Europe designs and markets an innovative area decontamination technology that provides disinfection of patient environments such as hospital and operating rooms. This technology generates a dry mist of hydrogen peroxide on all surfaces for broad and efficient disinfection. Gloster Europe's products have gained significant momentum in Europe and the Middle East and have achieved scientific recognition for their effectiveness against superbugs, such as MRSA and C.difficile, as well as many other viruses and fungi.

"Area decontamination technology is a perfect strategic complement to ASP's existing portfolio of surgical instrument sterilization, high-level disinfection and hand hygiene solutions," said Chuck Austin, Worldwide President of ASP. "Healthcare-acquired infections are a growing global concern. ASP is proud to offer patients who need hospital care greater peace of mind, knowing their room has the added infection protection benefit of this advanced and automated disinfection technology."

Never has the need been greater for novel area decontamination technologies with healthcare-acquired infection rates rising across the globe. Healthcare-acquired infections are at unacceptable rates with an incidence of 4.5 percent of hospital admissions in the U.S. and Western Europe and as high as 15 percent in emerging markets.(1)

Gloster Europe's technologies, marketed under the STERINIS® brand name, are currently available in Europe, the Middle East and select countries in Africa and Asia with rapid expansion to other markets planned for 2010 and beyond, pending country-specific regulations.

About Advanced Sterilization Products (ASP)

Advanced Sterilization Products (ASP) division of Ethicon, Inc., a member of the Johnson & Johnson Family of Companies, is a leading developer of innovative instrument sterilization, high level disinfection and cleaning technologies. The company is dedicated to protecting patients, healthcare workers, and the environment with products that focus as much on safety as they do on efficacy and cost-effectiveness. Utilizing advanced instrument processing technologies, these products help customers to promote positive patient outcomes while controlling costs, increasing productivity and enhancing safety. The company is based in Irvine, California, with offices around the world.

© Ethicon, Inc. 2009

(1) Centers of Disease Control and Prevention. Estimates on HealthCare Associated Infections. Available at: http://www.cdc.gov/ncidod/dhqp/hai.html. Accessed October 2007.

SOURCE Advanced Sterilization Products


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2017)... , July 13, 2017 It should come ... States is in the midst of a crippling ... , since 1999, the number of overdose deaths from opiate-based ... in over half a million dead from 2001 to 2015". ... oxycodone, and hydrocodone has similarly quadrupled, drawing a compelling link ...
(Date:7/12/2017)... , July 12, 2017  Eli Lilly and Company (NYSE: ... with generic companies to resolve pending patent litigation in the ... Virginia regarding the Cialis ® (tadalafil) unit ... April 26, 2020. As part of the agreement, Cialis exclusivity ... 27, 2018. "The unit dose patent for Cialis ...
(Date:7/11/2017)... SARASOTA, Fla. , July 11, 2017  Dr. Echenberg, founder of ... Dilator therapy program to patients who suffer from painful intercourse and other ... vaginismus and vaginal atrophy due to menopause. ... VuVatech LLC ... Dilators , created by Sarasota, Florida -based start-up company, ...
Breaking Medicine Technology:
(Date:7/26/2017)... Washington, DC (PRWEB) , ... July 26, 2017 ... ... Arise Infusion is pleased to now offer a major advancement in drug therapy ... their lives. Ocrevus (pronounced Ah-creh-vus) is a novel B cell targeted therapy ...
(Date:7/26/2017)... Yorba Linda, Ca (PRWEB) , ... July 26, 2017 , ... ... of optimize lyophilization processes. Inconsistent results freeze drying samples and a lengthy freeze dry ... , This webinar will discuss freeze drying techniques, as well as new accessories and ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... host its 2017 Process Validation and Process Validation Statistics Conferences in Bethesda, ... process validation lifecycle challenges faced by process validation professionals and statisticians today. ...
(Date:7/26/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of education, ... announce the 106 college athletes with type 1 diabetes who will receive scholarships as ... 1 Foundation has bestowed a total of 271 college scholarships to athletes with type ...
(Date:7/26/2017)... ... July 26, 2017 , ... IDC-Eating Disorder Care ... the treatment program located in Royal Oak, Michigan. IDC, formerly known as ... focused on providing the highest standards in the field of eating disorder treatment in ...
Breaking Medicine News(10 mins):